493 related articles for article (PubMed ID: 19476613)
1. DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.
Lenert P; Yasuda K; Busconi L; Nelson P; Fleenor C; Ratnabalasuriar RS; Nagy PL; Ashman RF; Rifkin IR; Marshak-Rothstein A
Arthritis Res Ther; 2009; 11(3):R79. PubMed ID: 19476613
[TBL] [Abstract][Full Text] [Related]
2. Guanine modification of inhibitory oligonucleotides potentiates their suppressive function.
Römmler F; Jurk M; Uhlmann E; Hammel M; Waldhuber A; Pfeiffer L; Wagner H; Vollmer J; Miethke T
J Immunol; 2013 Sep; 191(6):3240-53. PubMed ID: 23966630
[TBL] [Abstract][Full Text] [Related]
3. Guanine-modified inhibitory oligonucleotides efficiently impair TLR7- and TLR9-mediated immune responses of human immune cells.
Römmler F; Hammel M; Waldhuber A; Müller T; Jurk M; Uhlmann E; Wagner H; Vollmer J; Miethke T
PLoS One; 2015; 10(2):e0116703. PubMed ID: 25695778
[TBL] [Abstract][Full Text] [Related]
4. Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor-7 agonists and antagonists in BXSB mice.
Layer T; Steele A; Goeken JA; Fleenor S; Lenert P
Clin Exp Immunol; 2011 Mar; 163(3):392-403. PubMed ID: 21235537
[TBL] [Abstract][Full Text] [Related]
5. Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus.
Lenert PS
Arthritis Res Ther; 2006; 8(1):203. PubMed ID: 16542467
[TBL] [Abstract][Full Text] [Related]
6. DNA Nanoflowers' Amelioration of Lupus Symptoms in Mice via Blockade of TLR7/9's Signal.
Wang J; Gan M
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555668
[TBL] [Abstract][Full Text] [Related]
7. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
[TBL] [Abstract][Full Text] [Related]
8. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus.
Thibault DL; Graham KL; Lee LY; Balboni I; Hertzog PJ; Utz PJ
Arthritis Res Ther; 2009; 11(4):R112. PubMed ID: 19624844
[TBL] [Abstract][Full Text] [Related]
9. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.
Lau CM; Broughton C; Tabor AS; Akira S; Flavell RA; Mamula MJ; Christensen SR; Shlomchik MJ; Viglianti GA; Rifkin IR; Marshak-Rothstein A
J Exp Med; 2005 Nov; 202(9):1171-7. PubMed ID: 16260486
[TBL] [Abstract][Full Text] [Related]
10. Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.
Nündel K; Green NM; Shaffer AL; Moody KL; Busto P; Eilat D; Miyake K; Oropallo MA; Cancro MP; Marshak-Rothstein A
J Immunol; 2015 Mar; 194(6):2504-12. PubMed ID: 25681333
[TBL] [Abstract][Full Text] [Related]
11. Activation of rheumatoid factor-specific B cells is antigen dependent and occurs preferentially outside of germinal centers in the lupus-prone NZM2410 mouse model.
Sang A; Niu H; Cullen J; Choi SC; Zheng YY; Wang H; Shlomchik MJ; Morel L
J Immunol; 2014 Aug; 193(4):1609-21. PubMed ID: 25015835
[TBL] [Abstract][Full Text] [Related]
12. Toll-Like Receptor-Dependent Immune Complex Activation of B Cells and Dendritic Cells.
Moody KL; Uccellini MB; Avalos AM; Marshak-Rothstein A; Viglianti GA
Methods Mol Biol; 2016; 1390():249-72. PubMed ID: 26803634
[TBL] [Abstract][Full Text] [Related]
13. B and T cell tolerance and autoimmunity in autoantibody transgenic mice.
Yan J; Mamula MJ
Int Immunol; 2002 Aug; 14(8):963-71. PubMed ID: 12147633
[TBL] [Abstract][Full Text] [Related]
14. AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.
White CA; Seth Hawkins J; Pone EJ; Yu ES; Al-Qahtani A; Mai T; Zan H; Casali P
Autoimmunity; 2011 Dec; 44(8):585-98. PubMed ID: 21585311
[TBL] [Abstract][Full Text] [Related]
15. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides.
Brummel R; Lenert P
J Immunol; 2005 Feb; 174(4):2429-34. PubMed ID: 15699180
[TBL] [Abstract][Full Text] [Related]
16. Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.
Anders HJ; Vielhauer V; Eis V; Linde Y; Kretzler M; Perez de Lema G; Strutz F; Bauer S; Rutz M; Wagner H; Gröne HJ; Schlöndorff D
FASEB J; 2004 Mar; 18(3):534-6. PubMed ID: 14734643
[TBL] [Abstract][Full Text] [Related]
17. A novel BAFF antagonist, BAFF-Trap, effectively alleviates the disease progression of systemic lupus erythematosus in MRL/lpr mice.
Yu C; Chen S; Zhou B; Zhang H; Su X; Luo Y; Yang L
Mol Immunol; 2021 Jan; 129():1-11. PubMed ID: 33254074
[TBL] [Abstract][Full Text] [Related]
18. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
Brummel R; Roberts TL; Stacey KJ; Lenert P
Eur J Immunol; 2006 Jul; 36(7):1951-62. PubMed ID: 16791898
[TBL] [Abstract][Full Text] [Related]
19. B cells and dendritic cells from V kappa 8 light chain transgenic mice activate MRL-lpr/gld CD4+ T cells.
Beaudette-Zlatanova BC; Ling T; Shlomchik MJ; Marshak-Rothstein A; Rifkin IR
J Immunol; 2006 Jul; 177(1):45-52. PubMed ID: 16785497
[TBL] [Abstract][Full Text] [Related]
20. Tonic B cell activation by Radioprotective105/MD-1 promotes disease progression in MRL/lpr mice.
Kobayashi T; Takahashi K; Nagai Y; Shibata T; Otani M; Izui S; Akira S; Gotoh Y; Kiyono H; Miyake K
Int Immunol; 2008 Jul; 20(7):881-91. PubMed ID: 18492657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
